Spinal Cord Stimulation —
pain relief without more surgery

Yes — prior surgery is not a requirement. While failed back surgery syndrome is the most historically established SCS indication, the procedure is appropriate for any chronic pain condition with a neuropathic component that has not responded to conservative management and for which a structural surgical solution is either absent or not the right next step. Painful diabetic neuropathy, complex regional pain syndrome, chronic non-specific back pain without a discrete surgical target, and high surgical-risk patients with structural disease are all legitimate SCS candidates without prior surgery. The consultation establishes whether your specific pain pattern, diagnosis, and history make you an appropriate candidate.

The trial leads are placed as a clinic or outpatient procedure under fluoroscopy, typically under local anesthesia with mild sedation. You go home the same day with the external pulse generator — a small device similar in size to a pager or small remote, worn in a belt clip or pocket. You use the device at home during normal daily activities: sleeping, walking, sitting, driving (at appropriate times). Pain levels are recorded daily. Programming is adjusted at follow-up visits or remotely. The wires exit through the skin during the trial and are secured with tape — shower restrictions apply. At the end of the trial (typically 5–14 days), the leads are pulled out in the clinic — a simple, brief, office-based procedure requiring no anesthesia. If the trial worked, you decide whether to proceed to permanent implant. If it did not, you have no permanent hardware and are no worse off than before.

SCS works best for pain with a neuropathic component — burning, shooting, electric, or radiating pain that has a nerve-mediated character. Axial mechanical pain (pain purely from joint loading, purely positional) tends to respond less well. The pain patterns that respond best include: chronic radiating back and leg pain after surgery, burning or electric foot and leg pain from neuropathy, and mixed axial and neuropathic pain in the context of prior lumbar surgery or diffuse structural disease. The consultation includes a careful characterization of your pain pattern — burning vs. mechanical, constant vs. movement-triggered, distribution — to assess SCS suitability before proceeding to trial.

Modern SCS systems are MRI-conditional — meaning MRI can be performed under specific conditions (field strength, body region, SAR limits) as defined in the device labeling. This is a critical consideration for spine patients who are likely to need ongoing MRI surveillance of their spinal pathology. The device selected for implant is specifically chosen based on your anticipated imaging needs. The conditions for safe MRI are documented in writing and provided to the patient and their physicians. Full-body 1.5 Tesla MRI is available with most modern SCS systems under appropriate conditions. Your referring physicians are informed of the specific MRI requirements for your device at the time of implant.

Yes — SCS trial and permanent implantation are covered by Medicare and most major commercial insurers for appropriate indications, including failed back surgery syndrome, complex regional pain syndrome, and — as of FDA approval — painful diabetic neuropathy with high-frequency (10-kHz) systems. Coverage typically requires documentation of: chronic pain of sufficient duration (usually ≥6 months); failure of conservative management including medications and physical therapy; psychological evaluation clearance; and, for FBSS, prior spine surgery documentation. Prior authorisation is required. The practice manages insurance coordination and documentation for all SCS patients. Coverage for specific indications varies by insurer and plan; requirements are reviewed at the time of consultation.

Possibly — and this is one of the most important consultations to have before committing to a high-risk structural surgery. SCS is not a substitute for structural surgery that is clearly indicated and the patient can safely undergo. But for patients where the surgery needed is large, the risk is high, or the expected benefit is uncertain, SCS can provide meaningful pain relief with a fraction of the physiological cost. A consultation with Dr. Katsevman establishes whether the structural surgery is truly necessary and safely tolerable, whether SCS is an appropriate alternative or bridge, and whether starting with a low-risk trial implant is the right first step before committing to a major reconstruction. Many patients who thought they faced only a high-risk surgery have found that SCS — trialled at low risk — provided the relief they needed without the operation they feared.